Patients with chronic kidney disease (CKD) are at an increased risk of premature mortality,
mainly from cardiovascular causes. The association between CKD on hemodialysis and …

Hyperphosphatemia or even serum phosphate levels within the “normal laboratory range”
are highly associated with increased cardiovascular disease risk and mortality in the general …

Elevated levels of fibroblast growth factor 23 (FGF23) and phosphate are highly associated
with increased cardiovascular disease and mortality in patients suffering from chronic kidney …

Phosphorus, present as phosphate in biological systems, is an essential mineral for various
biological activities and biochemical processes. Numerous studies have indicated that …

Background & Aims The pathogenesis and progression of non-alcoholic fatty liver disease
(NAFLD) is still incompletely understood. Several nuclear receptors play a role in liver lipid …

Background Despite epidemiologic evidence for increased cardiovascular morbidity and
mortality associated with both high dietary and serum phosphate in humans with normal …

Results Prevalence of atheromatosis was 68.7% and progressed in 59.8% of patients after
24 months. CKD progression was associated with atheromatosis progression, suggesting a …

Cardiovascular risk management is an integral part of treatment in Type 2 Diabetes Mellitus
(T2DM), and requires pharmacological as well as nutritional management. We hypothesize …

Chronic kidney disease mineral and bone disorder (MBD) encompasses changes in mineral
ion and vitamin D metabolism that are widespread in the setting of chronic kidney disease …

Phosphorus is a vital element for life found in most foods as a natural component, but it is
also one of the most used preservatives added during food processing. High serum …